Artificial scientists
AI companies including Google DeepMind, OpenAI, and Anthropic are developing AI systems to act as autonomous researchers and co-scientists that can generate hypotheses, design experiments, and conduct scientific research with minimal human oversight. Recent breakthroughs include OpenAI connecting GPT-5 to automated biological labs to iteratively propose and test experiments, achieving a 40% cost reduction in protein synthesis, while researchers at Stanford created a "virtual lab" of AI agents that designed new antibody fragments against SARS-CoV-2. However, research suggests that widespread AI adoption in science may inadvertently reduce scientific diversity by concentrating research on data-rich, established topics while leaving fewer scientists to explore problems less amenable to AI analysis.




